Healthcare & pharmaceutical debt advisory
Pharmaceutical Manufacturing Project Finance
Structure funding for API units, formulation plants, sterile injectables and pharmaceutical manufacturing expansion.
Pharmaceutical Manufacturing Project Finance in India
Pharma project finance supports a defined capital-investment programme for pharmaceutical manufacturing. CreditCares helps promoters organise proposals for new plant construction, production capacity expansion and facility upgrades. A bankable proposal connects the manufacturing process, product portfolio, approval pathway and customer demand to the project’s cost and repayment schedule.
What can the funding proposal cover?
- API and bulk-drug plant finance
- New synthesis blocks, process equipment, utilities and related project infrastructure.
- Formulation plant finance
- Manufacturing lines for tablets, capsules and other formulations, with packaging and quality-control infrastructure.
- Sterile injectable plant finance
- Specialised production areas, cleanroom infrastructure, utilities and equipment within a documented implementation plan.
- WHO-GMP facility upgrade finance
- A defined capital programme for manufacturing and quality-system upgrades. Financing does not confer certification or regulatory approval.
How lenders assess the proposal
Separate civil works, production machinery, utilities, validation and pre-operative costs. Explain installed capacity, planned utilisation, product mix, customer concentration and the time between commissioning and commercial sales. For an expansion, reconcile existing capacity and sales with the proposed increase. Regulatory readiness and cash-flow assumptions need evidence, not simply a higher turnover projection.
Documents to prepare
- Company and promoter KYC, shareholding and group exposure details
- Detailed project report with process flow, product mix and capacity assumptions
- Land or lease documents, factory layout and construction estimates
- Supplier quotations, machinery specifications and payment milestones
- Manufacturing licences and applicable approval or certification status
- Audited accounts, bank statements, existing debt and projected debt-service calculations
The final checklist depends on the lender, project stage and legal structure. Share a project summary first; detailed documents can follow through an agreed channel.
From initial review to lender appraisal
- Define the requirement. Share your entity, location, funding amount, purpose, existing borrowing and project stage.
- Prepare the proposal. Organise the financial information, cost estimates, assumptions and approval status relevant to your project.
- Compare lender terms. Review eligible facility structures, security, contribution, covenants and total costs before deciding.
- Complete appraisal and documentation. Lender due diligence, sanction conditions and disbursement requirements determine the next steps.
Advisory for Kolkata, West Bengal and across India
Discuss pharma project finance with CreditCares for projects in Kolkata, West Bengal, Mumbai and other Indian markets. A location-specific proposal should explain the site, demand, operating model and lender requirements. See our operational hubs or learn about CreditCares.
Frequently asked questions
What can pharma project finance cover?
A proposal can include plant construction, production machinery, utilities and related eligible project costs. Each lender decides the costs, margins and security it will accept.
Can an API or bulk-drug unit apply?
Yes. API and bulk-drug proposals need a clear process, utilities plan, approval status, project budget and evidence supporting commercial viability.
Can a WHO-GMP upgrade be financed?
A facility upgrade may be presented for term funding. The borrower must document the work and applicable standards; lender approval does not replace regulatory assessment or certification.
Is working capital included in a pharma plant loan?
Not automatically. Raw-material stocks and receivables should be assessed separately from fixed-asset investment, with an appropriate working-capital facility where eligible.
Can a new sterile injectable plant be considered?
Yes, subject to lender appetite and appraisal. Build realistic commissioning, validation and sales assumptions into the proposal, including adequate promoter contribution and contingencies.
Discuss your healthcare or pharma funding plan
Have your project location, estimated funding need, promoter contribution and existing debt ready for the first conversation.
CreditCares provides financing advisory. Approval, pricing, security and disbursement are decided by the lender following appraisal. No approval or rate is guaranteed.
General lender reference: SBI corporate finance products. These references illustrate lender products, not a CreditCares offer or a bank partnership.